Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Convenient Parameter for Predicting Behçet's Disease Severity: Lactate Dehydrogenase/Albumin Ratio

NCT06276829 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT06276829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06276829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Convenient Parameter for Predicting Behçet's Disease Severity: Lactate Dehydrogenase/Albumin Ratio
Lead sponsor
Ataturk University
Phase
Observational
Overall status
Completed
Start date
February 1, 2020
Completion date
April 1, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albumin, behcet's disease, disease severity, lactate dehydrogenase